Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.17 - $5.74 $654,560 - $901,002
-156,969 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$5.28 - $9.64 $14,451 - $26,384
-2,737 Reduced 1.71%
156,969 $829,000
Q4 2020

Feb 16, 2021

BUY
$5.75 - $7.13 $109 - $135
19 Added 0.01%
159,706 $1.04 Million
Q3 2020

Nov 16, 2020

BUY
$4.9 - $7.12 $62,372 - $90,630
12,729 Added 8.66%
159,687 $976,000
Q2 2020

Aug 14, 2020

SELL
$6.43 - $9.86 $100,976 - $154,841
-15,704 Reduced 9.65%
146,958 $1.07 Million
Q1 2020

May 14, 2020

SELL
$6.36 - $10.05 $171 - $271
-27 Reduced 0.02%
162,662 $1.13 Million
Q4 2019

Feb 14, 2020

SELL
$8.49 - $12.81 $3,030 - $4,573
-357 Reduced 0.22%
162,689 $1.44 Million
Q3 2019

Nov 14, 2019

SELL
$5.58 - $14.47 $27,749 - $71,959
-4,973 Reduced 2.96%
163,046 $1.83 Million
Q2 2019

Aug 15, 2019

BUY
$5.22 - $9.08 $877,059 - $1.53 Million
168,019 New
168,019 $1.02 Million

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.